Results 171 to 180 of about 806,967 (237)
"Our kids are our future": Barriers and facilitators to vaccine uptake and timeliness among Aboriginal children younger than five years in Boorloo (Perth), Western Australia. [PDF]
Puca C+12 more
europepmc +1 more source
Grafts used to construct lung cancer animal models come from various sources, primarily cell lines, patient‐derived tumor tissues, and circulating tumor cells. Based on the sources of grafts and research objectives, lung cancer animal models can be categorized into several types: chemical‐induced models, orthotopic transplantation models, heterotopic ...
Zixuan Yang+7 more
wiley +1 more source
An Overview of the H5N1 mRNA Vaccine Pipeline. [PDF]
Focosi D, Nicastri E, Maggi F.
europepmc +1 more source
Bifidobacterium animalis subsp. lactis modulates early‐life immune response and gut metabolism
Background: The maturation of the immune system is critical during early life, as it involves the differentiation, maturation, and establishment of immune tolerance of immune cells. This process is influenced not only by genetic factors but also by environmental factors, particularly the symbiotic microbiota. Bifidobacterium animalis subsp.
Haoming Du+17 more
wiley +1 more source
Emerging Immunotherapies in Lung Cancer: The Latest Advances and the Future of mRNA Vaccines. [PDF]
Ramos R, Vale N.
europepmc +1 more source
Objective To compare clinical and radiological outcomes among relapsing multiple sclerosis patients treated with autologous hematopoietic stem cell transplantation (AHSCT), alemtuzumab (ATZ), and ocrelizumab (OCR). Methods From a London (UK) hospital‐based observational cohort, modeled data were obtained from 621 relapsing–remitting multiple sclerosis ...
Paolo Antonio Muraro+16 more
wiley +1 more source
Advances in mRNA vaccine therapy for breast cancer research. [PDF]
Li JY, Jiang RY, Wang J, Wang XJ.
europepmc +1 more source
New Horizons for Multiple Sclerosis Therapy: 2025 and Beyond
The advances achieved against multiple sclerosis (MS) represent one of the great success stories of modern molecular medicine. The development of therapies with increasing selectivity and safety, guided by gains in understanding the fundamental immunology, neurobiology, genetics, and triggers of this disease, have broadened the traditional focus on ...
Joseph J. Sabatino Jr.+2 more
wiley +1 more source
The role of the right valuation method in setting the firm's break-even price for mpox (and other) vaccines. [PDF]
Engelen PJ, Cassimon D.
europepmc +1 more source
Lanthanide‐based luminescence nanothermometry holds multifaceted potential for nanomedical applications, yet despite significant research advances, clinical translation of the engineered nanomaterials is still controversial and widely disputed. This is related to crucial nanotoxicological aspects that must be addressed at the preclinical level ...
Simona Premcheska+2 more
wiley +1 more source